Technology Validation Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its supply contract with the UK Department of Health and Social Care (DHSC) and provides an unaudited trading update for the three months ended 31 March 2021. DHSC contract On 29 September 2020, Novacyt announced a second supply contract with the DHSC for exsig COVID-19 Direct kits and other products. In the full year trading update announced on 29 January 2021, Novacyt explained it was in active discussions with the DHSC regarding an extension of the supp...

RNS Number: 1141 Q Novacyt S.A. 24 February 2021 Novacyt S.A.. Paris, France and Camberley, UK- 24 February 2021- Novacyt, an international specialist...

    This is a correction to the Research and Development Update announcement published at 7:00am on 24 February 2021 (RNS number 1141Q) which has been amended with the following underlined additions to make it consistent with the French announcement released on Euronext at 8:00am CET on 24 February 2021.   Under the subtitle 'Launch of CE Mark COVID-HT Direct' · Novacyt announces the launch of its next generation high-throughput PCR test for COVID-19 (COVID-HT Direct), which has been CE Mark approved using independent validated data. · ...

Investegate announcements from QuantuMDx Group Ltd, Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx

QuantuMDx Group Ltd: Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx - QuantuMDx has developed Q-POC - a rapid, PCR diagnostic device for coronavirus testing at the point of care NEWCASTLE UPON TYNE, UK, 13 February 2021. QuantuMDx Group Limited, a UK-based diagnostics company which has developed a revolutionary 30 minute PCR diagnostics device, Q-POC , and accompanying SARS-CoV-2 test, today welcomed the Prime Minister, Rt Hon Boris Johnson MP, for a tour of its purpose-built HQ in Newcastle upon Tyne. Q-POC is an innovative portable, Polymerase Chain Reaction ('PCR') de...